Geoff Meacham
Stock Analyst at Citigroup
(3.64)
# 780
Out of 4,863 analysts
248
Total ratings
52.94%
Success rate
4.47%
Average return
Main Sectors:
Stocks Rated by Geoff Meacham
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ABOS Acumen Pharmaceuticals | Initiates: Buy | $4 | $1.14 | +252.42% | 4 | Jun 17, 2025 | |
| NVAX Novavax | Initiates: Sell | $6 | $7.03 | -14.65% | 1 | Jun 17, 2025 | |
| RNA Avidity Biosciences | Maintains: Buy | $70 → $75 | $29.80 | +151.68% | 6 | Jun 10, 2025 | |
| REGN Regeneron Pharmaceuticals | Maintains: Buy | $700 → $650 | $522.68 | +24.36% | 22 | Jun 2, 2025 | |
| ABBV AbbVie | Downgrades: Neutral | $210 → $205 | $190.86 | +7.41% | 17 | May 14, 2025 | |
| KYMR Kymera Therapeutics | Maintains: Neutral | $47 → $44 | $46.84 | -6.06% | 5 | May 12, 2025 | |
| PTCT PTC Therapeutics | Upgrades: Neutral | $50 → $40 | $51.87 | -22.88% | 8 | May 7, 2025 | |
| BNTX BioNTech SE | Maintains: Buy | $145 → $140 | $106.33 | +31.67% | 2 | May 6, 2025 | |
| NMRA Neumora Therapeutics | Downgrades: Underperform | $7 → $1 | $0.86 | +15.79% | 3 | Apr 2, 2025 | |
| MRNA Moderna | Initiates: Neutral | $40 | $26.00 | +53.85% | 10 | Mar 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $40 | $28.44 | +40.67% | 3 | Mar 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $95 | $42.61 | +122.95% | 2 | Mar 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $25 | $10.05 | +148.76% | 1 | Mar 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $99 → $103 | $56.24 | +83.14% | 3 | Feb 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $160 → $145 | $131.04 | +10.65% | 14 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $310 → $295 | $295.56 | -0.19% | 11 | Jan 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $98 → $85 | $41.58 | +104.43% | 2 | Jan 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $112 → $4 | $1.69 | +136.69% | 5 | Jan 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $42 → $45 | $41.14 | +9.38% | 5 | Nov 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $125 | $110.83 | +12.79% | 6 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $575 | $450.91 | +27.52% | 4 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $1,150 → $1,100 | $807.58 | +36.21% | 9 | Oct 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $120 → $20 | $10.09 | +98.22% | 3 | Oct 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $22 → $31 | $10.22 | +203.33% | 2 | Oct 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $10 | $0.35 | +2,772.74% | 2 | Aug 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $150 → $145 | $80.96 | +79.10% | 6 | Jul 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $180 → $170 | $155.22 | +9.52% | 3 | Apr 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $38 | $35.10 | +8.26% | 2 | Apr 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $24 → $48 | $23.61 | +103.30% | 2 | Mar 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $68 → $60 | $48.66 | +23.30% | 8 | Jan 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $8 | $1.22 | +555.74% | 2 | Dec 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $23 → $14 | $5.24 | +167.43% | 2 | Sep 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underperform | $10 → $8 | $5.52 | +44.93% | 4 | Aug 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 → $17 | $0.52 | +3,168.60% | 1 | Aug 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $50 → $45 | $24.40 | +84.43% | 6 | Apr 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $50 | $5.44 | +819.12% | 1 | Jan 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $24 | $2.00 | +1,100.00% | 4 | Nov 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $12 → $4 | $3.37 | +18.69% | 2 | Jun 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $28 | $1.41 | +1,892.88% | 1 | Aug 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $34 | $0.58 | +5,731.90% | 1 | Jul 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $56 | $4.94 | +1,033.60% | 3 | May 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $35 | $1.17 | +2,891.45% | 4 | Jan 15, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $525 | $3.32 | +15,737.10% | 1 | Nov 23, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $42 | $1.08 | +3,788.89% | 1 | Oct 20, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $20 | $6.62 | +202.11% | 1 | Sep 15, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $20 | $0.50 | +3,900.00% | 2 | Sep 8, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Underperform | $9 | $3.45 | +160.87% | 1 | Jun 25, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $60 | $9.16 | +555.02% | 1 | Jun 25, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Underperform | $7 | $4.17 | +67.87% | 1 | Jun 25, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $15 → $23 | $12.65 | +81.82% | 3 | Aug 5, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $90 → $82 | $71.22 | +15.14% | 9 | May 3, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $100 → $95 | $288.56 | -67.08% | 6 | Mar 1, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $300 → $80 | $9.55 | +737.70% | 3 | Dec 20, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $100 → $135 | $125.00 | +8.00% | 2 | Aug 1, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | n/a | $5.66 | - | 4 | May 21, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $16 → $20 | $0.67 | +2,898.95% | 4 | May 3, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | n/a | $15.18 | - | 2 | Apr 5, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $127 → $158 | $308.78 | -48.83% | 5 | Nov 8, 2017 |
Acumen Pharmaceuticals
Jun 17, 2025
Initiates: Buy
Price Target: $4
Current: $1.14
Upside: +252.42%
Novavax
Jun 17, 2025
Initiates: Sell
Price Target: $6
Current: $7.03
Upside: -14.65%
Avidity Biosciences
Jun 10, 2025
Maintains: Buy
Price Target: $70 → $75
Current: $29.80
Upside: +151.68%
Regeneron Pharmaceuticals
Jun 2, 2025
Maintains: Buy
Price Target: $700 → $650
Current: $522.68
Upside: +24.36%
AbbVie
May 14, 2025
Downgrades: Neutral
Price Target: $210 → $205
Current: $190.86
Upside: +7.41%
Kymera Therapeutics
May 12, 2025
Maintains: Neutral
Price Target: $47 → $44
Current: $46.84
Upside: -6.06%
PTC Therapeutics
May 7, 2025
Upgrades: Neutral
Price Target: $50 → $40
Current: $51.87
Upside: -22.88%
BioNTech SE
May 6, 2025
Maintains: Buy
Price Target: $145 → $140
Current: $106.33
Upside: +31.67%
Neumora Therapeutics
Apr 2, 2025
Downgrades: Underperform
Price Target: $7 → $1
Current: $0.86
Upside: +15.79%
Moderna
Mar 13, 2025
Initiates: Neutral
Price Target: $40
Current: $26.00
Upside: +53.85%
Mar 13, 2025
Initiates: Buy
Price Target: $40
Current: $28.44
Upside: +40.67%
Mar 13, 2025
Initiates: Buy
Price Target: $95
Current: $42.61
Upside: +122.95%
Mar 13, 2025
Initiates: Buy
Price Target: $25
Current: $10.05
Upside: +148.76%
Feb 20, 2025
Maintains: Buy
Price Target: $99 → $103
Current: $56.24
Upside: +83.14%
Feb 13, 2025
Maintains: Neutral
Price Target: $160 → $145
Current: $131.04
Upside: +10.65%
Jan 28, 2025
Maintains: Neutral
Price Target: $310 → $295
Current: $295.56
Upside: -0.19%
Jan 7, 2025
Maintains: Buy
Price Target: $98 → $85
Current: $41.58
Upside: +104.43%
Jan 7, 2025
Downgrades: Underperform
Price Target: $112 → $4
Current: $1.69
Upside: +136.69%
Nov 25, 2024
Maintains: Buy
Price Target: $42 → $45
Current: $41.14
Upside: +9.38%
Nov 14, 2024
Initiates: Buy
Price Target: $125
Current: $110.83
Upside: +12.79%
Nov 14, 2024
Initiates: Buy
Price Target: $575
Current: $450.91
Upside: +27.52%
Oct 31, 2024
Maintains: Buy
Price Target: $1,150 → $1,100
Current: $807.58
Upside: +36.21%
Oct 30, 2024
Downgrades: Underperform
Price Target: $120 → $20
Current: $10.09
Upside: +98.22%
Oct 18, 2024
Upgrades: Buy
Price Target: $22 → $31
Current: $10.22
Upside: +203.33%
Aug 19, 2024
Maintains: Buy
Price Target: $12 → $10
Current: $0.35
Upside: +2,772.74%
Jul 31, 2024
Maintains: Buy
Price Target: $150 → $145
Current: $80.96
Upside: +79.10%
Apr 17, 2024
Maintains: Neutral
Price Target: $180 → $170
Current: $155.22
Upside: +9.52%
Apr 12, 2024
Maintains: Buy
Price Target: $40 → $38
Current: $35.10
Upside: +8.26%
Mar 13, 2024
Maintains: Buy
Price Target: $24 → $48
Current: $23.61
Upside: +103.30%
Jan 3, 2024
Downgrades: Neutral
Price Target: $68 → $60
Current: $48.66
Upside: +23.30%
Dec 15, 2023
Downgrades: Neutral
Price Target: $8
Current: $1.22
Upside: +555.74%
Sep 8, 2023
Downgrades: Neutral
Price Target: $23 → $14
Current: $5.24
Upside: +167.43%
Aug 21, 2023
Maintains: Underperform
Price Target: $10 → $8
Current: $5.52
Upside: +44.93%
Aug 21, 2023
Maintains: Buy
Price Target: $19 → $17
Current: $0.52
Upside: +3,168.60%
Apr 21, 2023
Maintains: Neutral
Price Target: $50 → $45
Current: $24.40
Upside: +84.43%
Jan 5, 2023
Initiates: Buy
Price Target: $50
Current: $5.44
Upside: +819.12%
Nov 1, 2022
Downgrades: Underperform
Price Target: $24
Current: $2.00
Upside: +1,100.00%
Jun 8, 2022
Downgrades: Neutral
Price Target: $12 → $4
Current: $3.37
Upside: +18.69%
Aug 10, 2021
Initiates: Buy
Price Target: $28
Current: $1.41
Upside: +1,892.88%
Jul 13, 2021
Initiates: Buy
Price Target: $34
Current: $0.58
Upside: +5,731.90%
May 7, 2021
Upgrades: Buy
Price Target: $56
Current: $4.94
Upside: +1,033.60%
Jan 15, 2021
Downgrades: Neutral
Price Target: $35
Current: $1.17
Upside: +2,891.45%
Nov 23, 2020
Initiates: Buy
Price Target: $525
Current: $3.32
Upside: +15,737.10%
Oct 20, 2020
Initiates: Buy
Price Target: $42
Current: $1.08
Upside: +3,788.89%
Sep 15, 2020
Reinstates: Buy
Price Target: $20
Current: $6.62
Upside: +202.11%
Sep 8, 2020
Reinstates: Buy
Price Target: $20
Current: $0.50
Upside: +3,900.00%
Jun 25, 2020
Reinstates: Underperform
Price Target: $9
Current: $3.45
Upside: +160.87%
Jun 25, 2020
Reinstates: Buy
Price Target: $60
Current: $9.16
Upside: +555.02%
Jun 25, 2020
Initiates: Underperform
Price Target: $7
Current: $4.17
Upside: +67.87%
Aug 5, 2019
Maintains: Equal-Weight
Price Target: $15 → $23
Current: $12.65
Upside: +81.82%
May 3, 2019
Downgrades: Equal-Weight
Price Target: $90 → $82
Current: $71.22
Upside: +15.14%
Mar 1, 2019
Maintains: Underweight
Price Target: $100 → $95
Current: $288.56
Upside: -67.08%
Dec 20, 2018
Downgrades: Equal-Weight
Price Target: $300 → $80
Current: $9.55
Upside: +737.70%
Aug 1, 2018
Maintains: Overweight
Price Target: $100 → $135
Current: $125.00
Upside: +8.00%
May 21, 2018
Downgrades: Underweight
Price Target: n/a
Current: $5.66
Upside: -
May 3, 2018
Maintains: Equal-Weight
Price Target: $16 → $20
Current: $0.67
Upside: +2,898.95%
Apr 5, 2018
Downgrades: Equal-Weight
Price Target: n/a
Current: $15.18
Upside: -
Nov 8, 2017
Maintains: Overweight
Price Target: $127 → $158
Current: $308.78
Upside: -48.83%